Selected research
Market Structure
Global Metformin Hydrochloride Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Metformin Hydrochloride Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Metformin Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Metformin Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Metformin Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Metformin Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Metformin Hydrochloride Tablet include Novartis, Viatris, Torrent Pharmaceuticals, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Mallinckrodt, Dr. Reddy’s Laboratories, Bristol-Myers Squibb and Atlas Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Metformin Hydrochloride Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Metformin Hydrochloride Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Metformin Hydrochloride Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metformin Hydrochloride Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.
Metformin Hydrochloride Tablet Segment by Company
Novartis
Viatris
Torrent Pharmaceuticals
Teva Pharmaceuticals
Sun Pharmaceutical Industries
Mallinckrodt
Dr. Reddy’s Laboratories
Bristol-Myers Squibb
Atlas Pharmaceuticals
Apotex
Alkem
Metformin Hydrochloride Tablet Segment by Type
100 Tablets
50 Tablets
Other
Metformin Hydrochloride Tablet Segment by Application
Hospital
Drugs Stores
Metformin Hydrochloride Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Metformin Hydrochloride Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metformin Hydrochloride Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metformin Hydrochloride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Metformin Hydrochloride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 100 Tablets
- 50 Tablets
- Other
Applications
- Hospital
- Drugs Stores
Companies covered
- Novartis
- Viatris
- Torrent Pharmaceuticals
- Teva Pharmaceuticals
- Sun Pharmaceutical Industries
- Mallinckrodt
- Dr. Reddy’s Laboratories
- Bristol-Myers Squibb
- Atlas Pharmaceuticals
- Apotex
- Alkem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Metformin Hydrochloride Tablet Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Metformin Hydrochloride Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Metformin Hydrochloride Tablet Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Metformin Hydrochloride Tablet Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Metformin Hydrochloride Tablet Market Dynamics
- 2.1 Metformin Hydrochloride Tablet Industry Trends
- 2.2 Metformin Hydrochloride Tablet Industry Drivers
- 2.3 Metformin Hydrochloride Tablet Industry Opportunities and Challenges
- 2.4 Metformin Hydrochloride Tablet Industry Restraints
3 Metformin Hydrochloride Tablet Market by Manufacturers
- 3.1 Global Metformin Hydrochloride Tablet Revenue by Manufacturers (2021-2026)
- 3.2 Global Metformin Hydrochloride Tablet Sales by Manufacturers (2021-2026)
- 3.3 Global Metformin Hydrochloride Tablet Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Metformin Hydrochloride Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metformin Hydrochloride Tablet Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Metformin Hydrochloride Tablet Manufacturers, Product Type & Application
- 3.7 Global Metformin Hydrochloride Tablet Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metformin Hydrochloride Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metformin Hydrochloride Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Metformin Hydrochloride Tablet Tier 1, Tier 2, and Tier 3
4 Metformin Hydrochloride Tablet Market by Type
- 4.1 Metformin Hydrochloride Tablet Type Introduction
- 4.1.1 100 Tablets
- 4.1.2 50 Tablets
- 4.1.3 Other
- 4.2 Global Metformin Hydrochloride Tablet Sales by Type
- 4.2.1 Global Metformin Hydrochloride Tablet Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Metformin Hydrochloride Tablet Sales by Type (2021-2032)
- 4.2.3 Global Metformin Hydrochloride Tablet Sales Market Share by Type (2021-2032)
- 4.3 Global Metformin Hydrochloride Tablet Revenue by Type
- 4.3.1 Global Metformin Hydrochloride Tablet Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Metformin Hydrochloride Tablet Revenue by Type (2021-2032)
- 4.3.3 Global Metformin Hydrochloride Tablet Revenue Market Share by Type (2021-2032)
5 Metformin Hydrochloride Tablet Market by Application
- 5.1 Metformin Hydrochloride Tablet Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drugs Stores
- 5.2 Global Metformin Hydrochloride Tablet Sales by Application
- 5.2.1 Global Metformin Hydrochloride Tablet Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Metformin Hydrochloride Tablet Sales by Application (2021-2032)
- 5.2.3 Global Metformin Hydrochloride Tablet Sales Market Share by Application (2021-2032)
- 5.3 Global Metformin Hydrochloride Tablet Revenue by Application
- 5.3.1 Global Metformin Hydrochloride Tablet Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Metformin Hydrochloride Tablet Revenue by Application (2021-2032)
- 5.3.3 Global Metformin Hydrochloride Tablet Revenue Market Share by Application (2021-2032)
6 Global Metformin Hydrochloride Tablet Sales by Region
- 6.1 Global Metformin Hydrochloride Tablet Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Metformin Hydrochloride Tablet Sales by Region (2021-2032)
- 6.2.1 Global Metformin Hydrochloride Tablet Sales by Region (2021-2026)
- 6.2.2 Global Metformin Hydrochloride Tablet Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Metformin Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Metformin Hydrochloride Tablet Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Metformin Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Metformin Hydrochloride Tablet Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Metformin Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Metformin Hydrochloride Tablet Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Metformin Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Metformin Hydrochloride Tablet Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Metformin Hydrochloride Tablet Revenue by Region
- 7.1 Global Metformin Hydrochloride Tablet Revenue by Region
- 7.1.1 Global Metformin Hydrochloride Tablet Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Metformin Hydrochloride Tablet Revenue by Region (2021-2026)
- 7.1.3 Global Metformin Hydrochloride Tablet Revenue by Region (2027-2032)
- 7.1.4 Global Metformin Hydrochloride Tablet Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Metformin Hydrochloride Tablet Revenue (2021-2032)
- 7.2.2 North America Metformin Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Metformin Hydrochloride Tablet Revenue (2021-2032)
- 7.3.2 Europe Metformin Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Metformin Hydrochloride Tablet Revenue (2021-2032)
- 7.4.2 Asia-Pacific Metformin Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Metformin Hydrochloride Tablet Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Metformin Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Information
- 8.1.2 Novartis Business Overview
- 8.1.3 Novartis Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novartis Metformin Hydrochloride Tablet Product Portfolio
- 8.1.5 Novartis Recent Developments
- 8.2 Viatris
- 8.2.1 Viatris Company Information
- 8.2.2 Viatris Business Overview
- 8.2.3 Viatris Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Viatris Metformin Hydrochloride Tablet Product Portfolio
- 8.2.5 Viatris Recent Developments
- 8.3 Torrent Pharmaceuticals
- 8.3.1 Torrent Pharmaceuticals Company Information
- 8.3.2 Torrent Pharmaceuticals Business Overview
- 8.3.3 Torrent Pharmaceuticals Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Torrent Pharmaceuticals Metformin Hydrochloride Tablet Product Portfolio
- 8.3.5 Torrent Pharmaceuticals Recent Developments
- 8.4 Teva Pharmaceuticals
- 8.4.1 Teva Pharmaceuticals Company Information
- 8.4.2 Teva Pharmaceuticals Business Overview
- 8.4.3 Teva Pharmaceuticals Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Teva Pharmaceuticals Metformin Hydrochloride Tablet Product Portfolio
- 8.4.5 Teva Pharmaceuticals Recent Developments
- 8.5 Sun Pharmaceutical Industries
- 8.5.1 Sun Pharmaceutical Industries Company Information
- 8.5.2 Sun Pharmaceutical Industries Business Overview
- 8.5.3 Sun Pharmaceutical Industries Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sun Pharmaceutical Industries Metformin Hydrochloride Tablet Product Portfolio
- 8.5.5 Sun Pharmaceutical Industries Recent Developments
- 8.6 Mallinckrodt
- 8.6.1 Mallinckrodt Company Information
- 8.6.2 Mallinckrodt Business Overview
- 8.6.3 Mallinckrodt Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Mallinckrodt Metformin Hydrochloride Tablet Product Portfolio
- 8.6.5 Mallinckrodt Recent Developments
- 8.7 Dr. Reddy’s Laboratories
- 8.7.1 Dr. Reddy’s Laboratories Company Information
- 8.7.2 Dr. Reddy’s Laboratories Business Overview
- 8.7.3 Dr. Reddy’s Laboratories Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Dr. Reddy’s Laboratories Metformin Hydrochloride Tablet Product Portfolio
- 8.7.5 Dr. Reddy’s Laboratories Recent Developments
- 8.8 Bristol-Myers Squibb
- 8.8.1 Bristol-Myers Squibb Company Information
- 8.8.2 Bristol-Myers Squibb Business Overview
- 8.8.3 Bristol-Myers Squibb Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bristol-Myers Squibb Metformin Hydrochloride Tablet Product Portfolio
- 8.8.5 Bristol-Myers Squibb Recent Developments
- 8.9 Atlas Pharmaceuticals
- 8.9.1 Atlas Pharmaceuticals Company Information
- 8.9.2 Atlas Pharmaceuticals Business Overview
- 8.9.3 Atlas Pharmaceuticals Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Atlas Pharmaceuticals Metformin Hydrochloride Tablet Product Portfolio
- 8.9.5 Atlas Pharmaceuticals Recent Developments
- 8.10 Apotex
- 8.10.1 Apotex Company Information
- 8.10.2 Apotex Business Overview
- 8.10.3 Apotex Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Apotex Metformin Hydrochloride Tablet Product Portfolio
- 8.10.5 Apotex Recent Developments
- 8.11 Alkem
- 8.11.1 Alkem Company Information
- 8.11.2 Alkem Business Overview
- 8.11.3 Alkem Metformin Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Alkem Metformin Hydrochloride Tablet Product Portfolio
- 8.11.5 Alkem Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Metformin Hydrochloride Tablet Value Chain Analysis
- 9.1.1 Metformin Hydrochloride Tablet Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Metformin Hydrochloride Tablet Production Mode & Process
- 9.2 Metformin Hydrochloride Tablet Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Metformin Hydrochloride Tablet Distributors
- 9.2.3 Metformin Hydrochloride Tablet Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst